Recent data suggest that Ras isoforms H-ras and K-ras4B (hereafter K-ras) have partially opposing functions in stem cells and cancer stem cells25–27, indicating that Ras isoform-specific inhibitors might be required in cancer therapy. The gene discussed is KRAS; the disease is cancer.